Oppenheimer Upgrades Teva Pharma (TEVA) to Outperform
Tweet Send to a Friend
Oppenheimer upgraded Teva Pharma (NYSE: TEVA) from Perform to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
